152 related articles for article (PubMed ID: 37072278)
21. [Multidisciplinary approach to the endolymphatic sac tumour].
González-Bonet LG; Amoros-Sebastiá LI; Piquer-Belloch J; Riesgo P; Llacer JL; Gisbert-Aguilar J; Morell-Quadreny L
Neurocirugia (Astur); 2011 Dec; 22(6):567-73. PubMed ID: 22167288
[TBL] [Abstract][Full Text] [Related]
22. [Endolymphatic sac tumor: a rare tumor of internal ear. Report of two cases].
Cazals-Hatem D; Henin D; Bouccara D; Rey A; Cyna-Gorse F; Sterkers O; Degott C
Ann Pathol; 2000 Sep; 20(4):349-52. PubMed ID: 11015653
[TBL] [Abstract][Full Text] [Related]
23. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
[TBL] [Abstract][Full Text] [Related]
24. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene.
Skalova A; Síma R; Bohus P; Curík R; Lukás J; Michal M
Pathol Res Pract; 2008; 204(8):599-606. PubMed ID: 18423895
[TBL] [Abstract][Full Text] [Related]
25. Endolymphatic sac papillary tumor: a case report and review.
Yilmaz I; Bolat F; Demirhan B; Aydin V; Ozluoglu LN
Auris Nasus Larynx; 2008 Jun; 35(2):276-81. PubMed ID: 17855033
[TBL] [Abstract][Full Text] [Related]
26. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with analysis of von Hippel-Lindau gene and review.
Rao Q; Zhou J; Wang JD; Jin XZ; Ma HH; Lu ZF; Zhou XJ
Ann Diagn Pathol; 2010 Oct; 14(5):361-4. PubMed ID: 20850701
[TBL] [Abstract][Full Text] [Related]
27. Effects of VHL deficiency on endolymphatic duct and sac.
Gläsker S; Lonser RR; Tran MG; Ikejiri B; Butman JA; Zeng W; Maxwell PH; Zhuang Z; Oldfield EH; Vortmeyer AO
Cancer Res; 2005 Dec; 65(23):10847-53. PubMed ID: 16322231
[TBL] [Abstract][Full Text] [Related]
28. [Adenocarcinoma of the endolymphatic sac in von Hippel-Lindau disease. A case report].
Martínez-Miravete P; Domínguez P; Zubieta JL; Manrique M
Radiologia; 2007; 49(4):287-9. PubMed ID: 17594893
[TBL] [Abstract][Full Text] [Related]
29. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience.
Bell D; Gidley P; Levine N; Fuller GN
Ann Diagn Pathol; 2011 Apr; 15(2):117-23. PubMed ID: 21167761
[TBL] [Abstract][Full Text] [Related]
30. Intralabyrinthine sporadic endolymphatic sac tumour.
Lucas C; Leclère JC; Mornet E; Marianowski R
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Apr; 135(2):123-125. PubMed ID: 29117921
[TBL] [Abstract][Full Text] [Related]
31. Papillary neoplasm of the endolymphatic sac in a patient with von Hippel-Lindau disease.
Delisle MB; Uro E; Rouquette I; Yardeni E; Rumeau JL
J Clin Pathol; 1994 Oct; 47(10):959-61. PubMed ID: 7962613
[TBL] [Abstract][Full Text] [Related]
32. [Endolymphatic sac tumor and von Hippel-Lindau disease. Review of the literature].
de Minteguiaga C; García Ibáñez L; Tran Ba Huy P
Acta Otorrinolaringol Esp; 2002; 53(7):515-20. PubMed ID: 12487074
[TBL] [Abstract][Full Text] [Related]
33. Systematic Review of Endolymphatic Sac Tumor Treatment and Outcomes.
Tang JD; Grady AJ; Nickel CJ; Ryan LE; Malone A; Canvasser L; Boyev KP
Otolaryngol Head Neck Surg; 2023 Mar; 168(3):282-290. PubMed ID: 35763364
[TBL] [Abstract][Full Text] [Related]
34. Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease.
Nevoux J; Nowak C; Vellin JF; Lepajolec C; Sterkers O; Richard S; Bobin S
Otol Neurotol; 2014 Jun; 35(5):899-904. PubMed ID: 24662627
[TBL] [Abstract][Full Text] [Related]
35. Endolymphatic sac tumor in a patient with von Hippel-Lindau disease: MR imaging findings.
Kiliçkesmez O
Diagn Interv Radiol; 2006 Mar; 12(1):14-6. PubMed ID: 16538578
[TBL] [Abstract][Full Text] [Related]
36. Papillary adenoma of endolymphatic sac origin: a temporal bone tumor in von Hippel-Lindau disease. Case report.
Ouallet JC; Marsot-Dupuch K; Van Effenterre R; Kujas M; Tubiana JM
J Neurosurg; 1997 Sep; 87(3):445-9. PubMed ID: 9285613
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features of low-grade malignant endolymphatic sac tumors.
Wang HQ; Jie L; Shi HY
Pathol Res Pract; 2018 Mar; 214(3):431-435. PubMed ID: 29482989
[TBL] [Abstract][Full Text] [Related]
38. Current Treatment of Endolymphatic Sac Tumor of the Temporal Bone.
Mendenhall WM; Suárez C; Skálová A; Strojan P; Triantafyllou A; Devaney KO; Williams MD; Rinaldo A; Ferlito A
Adv Ther; 2018 Jul; 35(7):887-898. PubMed ID: 29923043
[TBL] [Abstract][Full Text] [Related]
39. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
[TBL] [Abstract][Full Text] [Related]
40. Re: Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in von Hippel-Lindau disease.
Torres JI; Megerian CA
Otol Neurotol; 2007 Dec; 28(8):1159; author reply 1161. PubMed ID: 17728688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
